Biểu đồ giá cổ phiếu DYN
DYN Thu nhập
Dyne Therapeutics, Inc
$18.44
0.38%
$0.07
Khi đóng cửa: May 13, 16:00:00 GMT-4
$18.5
0.32%
$0.05
Phiên trước giờ: May 14, 05:32:03 GMT-4
Quay lại
Dyne Therapeutics, Inc (DYN) Thu nhập
Thống kê chính
Giá đóng cửa trước
$18.37
Giá mở cửa
$18.43
Phạm vi ngày
$18.19 - $18.68
Phạm vi 52 tuần
$8.06 - $25
Khối lượng
898.2K
Khối lượng trung bình
2.0M
Tỷ suất cổ tức
--
EPS (TTM)
-3.54
Vốn hóa thị trường
$3.0B
DYN là gì?
Dyne Therapeutics, Inc. is a clinical-stage company, which engages in developing innovative life-transforming therapies for genetically driven muscle diseases. The company is headquartered in Waltham, Massachusetts and currently employs 258 full-time employees. The company went IPO on 2020-09-17. The company is discovering and advancing therapeutics for people living with genetically driven neuromuscular diseases. Leveraging the modularity of its FORCE platform, it is developing targeted therapeutics that deliver to muscle and central nervous system (CNS). The company has a broad pipeline for neuromuscular diseases, including clinical programs for myotonic dystrophy type 1 and Duchenne muscular dystrophy and preclinical programs for facioscapulohumeral muscular dystrophy and Pompe disease. Its product candidate, zeleciment basivarsen (also known as DYNE-101), is being evaluated in ACHIEVE, an ongoing Phase I/II global clinical trial in patients with DM1. Its product candidate, zeleciment rostudirsen (also known as DYNE-251), is being evaluated in DELIVER, an ongoing Phase I/II global clinical trial in patients with DMD who have mutations amenable to skipping exon 51. Its other product candidates are DYNE-302 and DYNE-401.
